Weekly Digest – August 2025 Weekly Digest – August 2025 12 August 2025: Idience and Aptis collaborate to develop next-generation dual payload ADC cancer drug Idience and Aptis have signed a joint development agreement to create next-generation dual payload antibody-drug […]
Weekly Digest – August 2025 Weekly Digest – August 2025 12 August 2025: Cohance Lifesciences announces $10 M investment in cGMP Bioconjugation Suite in US Cohance Lifesciences is investing $10 million to expand cGMP bioconjugation capabilities at its US-based subsidiary, […]
Weekly Digest – August 2025 Weekly Digest – August 2025 09 August 2025: Ipsen hands back Sutro’s ROR1 ADC at center of $875M deal Ipsen has exited an $875 million deal with Sutro Biopharma for the ROR1-targeted antibody-drug conjugate (ADC) […]
